MarketLens MarketLens
US: 2026-08-12 NSE: 2026-08-12 2026-08-12
Neutral
Menu

Stock Lookup

Search by symbol or company name, then inspect the chart and stock properties.

US

LGND Ligand Pharmaceuticals Incorporated

TradingView As Of 8/12/26
Analyst Data
Refresh analyst earnings estimates and rating summary for this symbol only.
Close
292.5000
Day %
1.30%
RS
87
Ind Rank
#51
RS 1D
87
RS 1W
89
RS 1M
92
RS 3M
75
RS 6M
67
Consensus Rating
Buy
Current Quarter EPS
1.01
Next Quarter EPS
1.20
Current Year EPS
5.47
Next Year EPS
6.63
ExchangeUS
Market Cap4 B
52W High326.6300
From 52W High-10.45%
Open290.3800
High294.5400
Low287.8100
OptionsNo
ActiveYes
RS TypeFull
RS Date2026-08-11
Bars Available310
Scanner Hits42
Last Scanner Hit2026-08-12

Recent Scanner History

42 matching / 42 total
Reset
Date Scanner RS
2026-08-12 Setup Scan
US_SETUP
87
2026-08-11 CANSLIM
US_CANSLIM
87
2026-08-10 Extreme Contraction
US_EXTREME_CONTRACTION
88
2026-08-10 CANSLIM
US_CANSLIM
88
2026-08-07 CANSLIM
US_CANSLIM
89
2026-08-05 Extreme Contraction
US_EXTREME_CONTRACTION
89
2026-08-04 Setup Scan
US_SETUP
89
2026-08-03 Setup Scan
US_SETUP
90
2026-07-13 Extreme Contraction
US_EXTREME_CONTRACTION
92
2026-07-09 Extreme Contraction
US_EXTREME_CONTRACTION
92

Analyst Snapshot

As Of 3/29/26
Consensus Current Quarter EPS Next Quarter EPS Current Year EPS Next Year EPS
Buy 1.01 1.20 5.47 6.63
Based on 4 analysts offering recommendations for 'LGND'.

Quarterly EPS Forecasts

4 rows
Period Consensus EPS High Low Estimates Revisions
Mar 2026 1.01 1.37 0.63 3
1 1
Jun 2026 1.20 1.40 1.07 3
0 2
Sep 2026 1.35 1.50 1.20 3
0 0
Dec 2026 1.41 1.57 1.27 3
0 0

Yearly EPS Forecasts

4 rows
Period Consensus EPS High Low Estimates Revisions
Dec 2026 5.47 7.10 4.42 4
2 2
Dec 2027 6.63 8.36 4.97 4
2 2
Dec 2028 6.09 6.86 5.31 2
0 0
Dec 2029 7.04 8.40 5.68 2
0 0